Publications by authors named "I Moret"

Article Synopsis
  • Chronic gut inflammation in Crohn’s disease (CD) is linked to increased oxidative stress and decreased catalase (CAT) enzyme activity.
  • A study analyzed data from 598 CD patients and 625 healthy controls, identifying significant SNPs in the CAT gene associated with CD and the severity of the disease in smokers.
  • Findings indicated that reduced CAT activity in white blood cells of CD patients is due to low protein levels from downregulated gene expression, suggesting a connection between CAT SNPs and the risk of developing CD.
View Article and Find Full Text PDF

Vector design and its characterization is an area of great interest in current vaccine research. In this article, we have formulated and characterized a multicompartmental lipopolyplex, which associates multiple liposomes and polyplexes in the same complex. These particles allow the simultaneous delivery of lipid or water-soluble antigens associated with genes to the same cell, in much higher amounts than conventional lipopolyplexes.

View Article and Find Full Text PDF

Inflammatory bowel disease (IBD) is a complex multifactorial disorder in which external and environmental factors have a large influence on its onset and development, especially in genetically susceptible individuals. Crohn's disease (CD), one of the two types of IBD, is characterized by transmural inflammation, which is most frequently located in the region of the terminal ileum. Oxidative stress, caused by an overabundance of reactive oxygen species, is present locally and systemically in patients with CD and appears to be associated with the well-described imbalanced immune response and dysbiosis in the disease.

View Article and Find Full Text PDF

Background: Cytokines emerge as possible biomarkers of response in Crohn's disease (CD). We aimed to determine the plasmatic cytokine profiles of active CD patients who started infliximab (IFX) treatment and their capacity to predict the response to IFX.

Methods: A total of 30 active CD patients receiving an induction therapy of IFX were enrolled in the study.

View Article and Find Full Text PDF

Inflammatory bowel disease (IBD) is a chronic and relapsing inflammatory condition of the gastrointestinal tract; it is a heterogeneous and multifactorial disorder resulting from a complex interplay between genetic variation, intestinal microbiota, the host immune system and environmental factors such as diet, drugs, breastfeeding and smoking. The interactions between dietary nutrients and intestinal immunity are complex. There is a compelling argument for environmental factors such as diet playing a role in the cause and course of IBD, given that three important factors in the pathogenesis of IBD can be modulated and controlled by diet: intestinal microbiota, the immune system and epithelial barrier function.

View Article and Find Full Text PDF